|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue: | |||||
| Cost of product and service revenue | |||||
| Inventory valuation charge | |||||
| Amortization of developed technology and backlog | |||||
| Total cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| General and administrative | |||||
| Change in fair value of contingent consideration | |||||
| Depreciation and amortization | |||||
| Long-lived assets impairment | |||||
| Goodwill impairment | |||||
| Total operating expenses | |||||
| (Loss) income from operations | |||||
| Interest income | |||||
| Legal settlement | |||||
| Interest expense | |||||
| Foreign currency gain (loss), net | |||||
| Gain on extinguishment of debt, net | |||||
| Other expense, net | |||||
| Total other expense | |||||
| (Loss) income before income tax expense (benefit) | |||||
| Income tax expense (benefit) | |||||
| Net (loss) income | |||||
| Preferred dividends and accretion | |||||
| Net (loss) income to common shareholders, basic | |||||
| Net (loss) income to common shareholders, diluted | |||||
| (Loss) income per common share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) |
Loading...